Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

21 Oct 2020 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg. The company has enclosed its press release on 21st October 2020.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..